Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome-Reference-Cited by-同舟云学术

Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome

Published:2014-07-16 Issue:9 Volume:12 Page:1440-1448
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Cugno M.¹,Gualtierotti R.¹,Possenti I.²,Testa S.²,Tel F.²,Griffini S.¹,Grovetti E.¹,Tedeschi S.²,Salardi S.²,Cresseri D.³,Messa P.³,Ardissino G.²

Affiliation:

1. Medicina Interna; Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti; Università degli Studi di Milano; Fondazione IRCCS Ca' Granda; Ospedale Maggiore Policlinico; Milan Italy

2. Center for HUS Prevention, Control and Management; Fondazione IRCCS Ca' Granda; Ospedale Maggiore Policlinico; Milan Italy

3. Unità Operativa di Nefrologia; Dialisi e Trapianto Renale; Fondazione IRCCS Ca' Granda; Ospedale Maggiore Policlinico; Milan Italy

Funder

Alexion Pharmaceuticals, Inc.

Associazione per la lotta alla Sindrome Emolitico Uremica (SEU)

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12615/fullpdf

Reference19 articles.

1. Atypical hemolytic-uremic syndrome;Noris;N Engl J Med,2009

2. Clinical grand rounds: atypical hemolytic uremic syndrome;Hodgkins;Am J Nephrol,2012

3. Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations;Kavanagh;Hematology Am Soc Hematol Educ Program,2011

4. Genetics and complement in atypical HUS;Kavanagh;Pediatr Nephrol,2010

5. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome;Józsi;Blood,2007

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept;Clinical Immunology;2024-07

2. A New Approach to Analyze the State of the Complement System in Patients with COVID-19. Pilot Study;Биологические мембраны Журнал мембранной и клеточной биологии;2024-06-14

3. Complement Biosensors Identify a Classical Pathway Stimulus in Complement-Mediated Hemolytic Uremic Syndrome;2024-06-02

4. Balancing efficacy and safety of complement inhibitors;Journal of Autoimmunity;2024-05

5. Complement-Mediated Thrombotic Microangiopathy after Kidney Transplant: Should Treatment with C5 Inhibitor Be Lifelong?;Nephron;2024-04-18